Akoya Biosciences introduces PhenoCode Discovery Panels to simplify PhenoCycler-Fusion workflow
17 Apr 2023
Akoya Biosciences, lauched its PhenoCode™ Discovery Panels, which simplify spatial biology workflows performed on the Akoya PhenoCycler-Fusion platform, at the American Association for Cancer Research (AACR) Annual Meeting 2023 in Florida, USA.
PhenoCode Discovery Panels are designed to advance cancer research by enabling thorough interrogation of tumors and the surrounding tumor microenvironment. Each of the ready-to-use, modular panels include biomarkers that can answer key biological questions related to immune profiling, lymphocyte profiling, tissue architecture, and immune activation and proliferation. Upfront assay development and validation time is significantly reduced, promising accelerated spatial discovery by 3x compared to standard workflows.
“The PhenoCode Discovery Panels further streamline and simplify the workflow on the PhenoCycler-Fusion System, offering new avenues of exploration for existing customers and paving the way for researchers who want to leverage this powerful technology for the first time,” said Brian McKelligon, CEO of Akoya. “These panels are an important part of the spatial biology ecosystem which Akoya has established and continues to expand. Our vision is to offer a comprehensive suite of panels for multiple applications. We expect to launch additional PhenoCode Discovery Panels for protein biomarkers throughout 2023 and 2024, and introduce panels for RNA in the second half of this year.”